Clindamycin is used in the treatment of soft tissue infections, dental infections and bone infections caused by susceptible strains of bacteria. It is available as 25mg, 150mg capsules and as drops containing 25mg/1ml. The drops should be stored at room temperature. The usual dose in dogs is 2.5-5mg/pound by mouth every 12 hours. The usual dose in cats is 5-10mg/pound by mouth once a day.

Fish Cin (Clindamycin 150mg), 60 Capsules Fish Cin is for use in aquariums and exerts a bactericidal action on gram positive and some gram negative bacteria.  Useful for control of some common bacterial fish diseases. Clindamycin inhibits bacterial protein synthesis via inhibition of bacterial ribosome.  It is primarily bacteriostatic, with spectrum of activity primarily against gram-positive bacteria and anaerobes.  Off-Label Use in Dogs & Cats:  Clindamycin is primarily used for gram-positive infections involving the skin, respiratory tract, or oral cavity.  Resistance with Staphylococcus may occur.  It is effective for some oral infections and anaerobic infections.  It also has been used for Mycoplasma infections.  Clindamycin and concentrate in leukocytes and may tissues. Fish:  Add one capsule (150mg) into aquarium for each 10 gallons of water.  Repeat in 24 hours.  It is suggested that a partial water change be made between treatments.  While treatment duration depends on the type and severity of infection, it is recommended that extended baths in the medication continue for a minimum of 5 days and for not more than 10 days.  Discontinued treatment if no improvement is noted within 5 days. Dogs and Cats:  Fish Cin is commonly given in off-label use to small animals. Anaerobic Infection Dog:  11 mg/Kg (5 mg/lb) every 12 hours orally. Cat:  11 mg/Kg (5 mg/lb) every 12 hours orally.  Staphylococcal Infections Dog:  11 mg/Kg (5 mg/lb) every 12 hours, or 22 mg/Kg (10 mg/lb) every 24 hours. Cat:  5.5 mg/Kg (2.5mg/lb) every 12 hours, or 11 mg/Kg (5 mg/lb) every 24 hours. Toxoplasmosis Dog:  12.5 mg/Kg (5.7 mg/lb) every 12 hours for 4 weeks. Cat:  12.5 mg/Kg (5.7 mg/lb) every 12 hours for 4 weeks. Do not administer to rabbits or rodents because it causes diarrhea.  Do not administer to horses or ruminants because it could cause severe enteritis.  Not for human use. Manufacturer:  Thomas Laboratories

Fish Cin (Clindamycin) 150 mg, 60 Capsules Fish Cin (Clindamycin) 150 mg, 60 Capsules is antibiotic for fish used to treat common bacterial diseases. When given off-label, Clindamycin is used in small animals for soft tissue infections (wounds & abscesses), dental infections and osteomyelitis. Fish Cin (Clindamycin 150mg), 60 Tablets Clindamycin Antibiotics for Fish Fish Cin is for use in aquariums and exerts a bactericidal action on gram positive and some gram negative bacteria. Useful for control of some common bacterial fish diseases. Off-Label Use in Dogs & Cats: Metronidazole is a antibacterial, antiprotozoal agent that has been used in the treatment of giardiasis, trichomoniasis, amoebiasis, balantidiasis, and trypanosomiasis. It is as effective and is better tolerated than quinacrine for the treatment of giardiasis. It is bactericidal to many anaerobic bacteria. It has been used in the treatment of septicemia, meningitis, peritonitis, biliary infections, colitis, and gingivostomatitis in which anaerobic bacteria are involved. The drug may also have immunosuppressive or immunostimulatory properties. Directions: Fish: Add one tablet (150mg) intoaquarium for each 10 gallons of water. Repeat in 24 hours. It is suggestedthat a partial water change be made between treatments. While treatmentduration depends on the type and severity of infection, it is recommendedthat extended baths in the medication continue for a minimum of 5 days andfor not more than 10 days. Discontinued treatment if no improvement isnoted within 5 days. Dogs and Cats: FishCin is commonly given in off-labeluse to small animals. Anaerobic Infection Dog: 11 mg/Kg (5 mg/lb) every 12 hours orally. Cat: 11 mg/Kg (5 mg/lb) every 12 hours orally. Staphylococcal Infections Dog: 11 mg/Kg (5 mg/lb) every 12 hours, or 22 mg/Kg (10 mg/lb) every 24 hours. Cat: 5.5 mg/Kg (2.5mg/lb) every 12 hours, or 11 mg/Kg (5 mg/lb) every 24 hours. Toxoplasmosis Dog: 12.5 mg/Kg (5.7 mg/lb) every 12 hours for 4 weeks. Cat: 12.5 mg/Kg (5.7 mg/lb) every 12 hours for 4 weeks. Do not administer to rabbits or rodents because itcauses diarrhea. Do not administer to horses or ruminants because itcould cause severe enteritis. Not for human use.

25 mg is only available in TABLETS Clindamycin is used in the treatment of soft tissue infections, dental infections and bone infections caused by susceptible strains of bacteria. Sold by the capsule. This medication is produced by various manufacturers. A prescription is required. You may mail in the prescription to us or we can contact the vet's office for the authorization. Please provide the vet?s name, number & your pet?s name on the 2nd page of the shopping cart. Once the veterinarian approves the prescription, we will ship the order within 24-72 hrs.

Clindamycin 150mg - 1 Caps. Use/info: Clindamycin is an antibiotic used to treat soft tissue, dental, and bone infections caused by susceptible strains of bacteria.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds, abscesses, dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds abscesses dental infections and soft tissue infections.

Clindamycin is used in the treatment of soft tissue infections, dental infections and bone infections caused by susceptible strains of bacteria. It is available as 25mg, 150mg capsules and as drops containing 25mg/1ml. The drops should be stored at room temperature. The usual dose in dogs is 2.5-5mg/pound by mouth every 12 hours. The usual dose in cats is 5-10mg/pound by mouth once a day. (sold per capsule)

Clindamycin 25mg. Use/info: Clindamycin is used in the treatment of soft tissue infections, dental infections and bone infections caused by susceptible strains of bacteria.

Clinsol Liquid 25 mg/ml, 20 mL (clindamycin) Clinsol Liquid 25 mg/ml, 20 mL (clindamycin) is an antibiotic effective in the treatment of wounds, abscesses, dental infections, osteomyelitis and skin infections in dogs and cats. CLINSOL ® LIQUID Clindamycin Pet Meds Virbac brand of clindamycin hydrochloride liquid DESCRIPTION Clinsol Liquid contains clindamycin hydrochloride which is the hydrated salt of clindamycin. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chlorosubstitution of the 7(R)-hydroxyl group of a naturally produced antibiotic produced by Streptomyces lincolnensis var. lincolnensis. Clinsol Liquid (For Use in Dogs and Cats) is a palatable formulation intended for oral administration. Each mL of Clinsol Liquid contains clindamycin hydrochloride equivalent to 25 mg clindamycin; and ethyl alcohol, 8.64%. ACTIONS Site and Mode of Action: Clindamycin is an inhibitor of protein synthesis in the bacterial cell. The site of binding appears to be in the 50S sub-unit of the ribosome. Binding occurs to the soluble RNA fraction of certain ribosomes, thereby inhibiting the binding of amino acids to those ribosomes. Clindamycin differs from cell wall inhibitors in that it causes irreversible modification of the protein-synthesizing subcellular elements at the ribosomal level. MICROBIOLOGY: Clindamycin is a lincosaminide antimicrobial agent with activity against a wide variety of aerobic and anaerobic bacterial pathogens. Clindamycin is a bacteriostatic compound that inhibits bacterial protein synthesis by binding to the 50S ribosomal sub-unit. The minimum inhibitory concentrations (MICs) of Gram-positive and obligate anaerobic pathogens isolated from dogs and cats in the United States are presented in Table 1 and Table 2. Bacteria were isolated in 1998-1999. All MICs were performed in accordance with the National Committee for Clinical Laboratory Standards (NCCLS). Table 1. Clindamycin MIC Values (µg/mL) from Diagnostic Laboratory Survey Data Evaluating Canine Pathogens in the U.S. during 1998-991 Organism Number of Isolates MIC 50 MIC 85 MIC 90 Range Soft Tissue/Wound 2 Staphylococcus aureus 17 0.5 0.5 ≥4.0 0.25-≥4.0 Staphylococcus intermedius 28 0.25 0.5 ≥4.0 0.125-≥4.0 Staphylococcus spp. 18 0.5 0.5 ≥4.0 0.25-≥4.0 Beta-hemolytic streptococci 46 0.5 0.5 ≥4.0 0.25-≥4.0 Streptococcus spp. 11 0.5 ≥4.0 ≥4.0 0.25-≥4.0 Osteomyelitis/Bone 3 Staphylococcus aureus 20 0.5 0.5 0.5 0.5 4 Staphylococcus intermedius 15 0.5 ≥4.0 ≥4.0 0.25-≥4.0 Staphylococcus spp. 18 0.5 ≥4.0 ≥4.0 0.25-≥4.0 Beta-hemolytic streptococci 21 0.5 2.0 2.0 0.25-≥4.0 Streptococcus spp. 21 ≥4.0 ≥4.0 ≥4.0 0.25-≥4.0 Dermal/Skin 5 Staphylococcus aureus 25 0.5 ≥4.0 ≥4.0 0.25-≥4.0 Staphylococcus intermedius 48 0.5 ≥4.0 ≥4.0 0.125-≥4.0 Staphylococcus spp. 32 0.5 ≥4.0 ≥4.0 0.25-≥4.0 Beta-hemolytic streptococci 17 0.5 0.5 0.5 0.25-0.5 1 The correlation between the in vitro susceptibility data and clinical response has not been determined. 2 Soft Tissue/Wound: includes samples labeled wound, abscess, aspirate, exudates, draining tract, lesion, and mass 3 Osteomyelitis/Bone: includes sa

Clintabs 150 mg, 100 Tablets (clindamycin) Clintabs 150 mg, 100 Tablets (clindamycin)is an antibiotic for pets indicated for the treatment of soft tissue infections, dental infections, and osteomyelitis. CLINTABS TABLETS Clindamycin for Dogs Virbac brand of clindamycin hydrochloride tablets ANADA # 200-316, Approved by FDA DESCRIPTION Clintabs (clindamycin hydrochloride) Tablets contain clindamycin hydrochloride which is the hydrated salt of clindamycin. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chlorosubstitution of the 7(R)-hydroxyl group of a naturally produced antibiotic produced by Streptomyces lincolnensis var. lincolnensis . Clintabs Tablets: 25 mg Tablet , each white tablet is marked "C 25" on one side and contains clindamycin hydrochloride equivalent to 25 mg of clindamycin. 75 mg Tablet , each white tablet is marked "C 75" on one side and contains clindamycin hydrochloride equivalent to 75 mg of clindamycin. 150 mg Tablet , each white tablet is marked "C150" on one side and contains clindamycin hydrochloride equivalent to 150 mg of clindamycin. ACTIONS Site and Mode of Action: Clindamycin is an inhibitor of protein synthesis in the bacterial cell. The site of binding appears to be in the 5OS sub-unit of the ribosome. Binding occurs to the soluble RNA fraction of certain ribosomes, thereby inhibiting the binding of amino acids to those ribosomes. Clindamycin differs from cell wall inhibitors in that it causes irreversible modification of the protein-synthesizing subcellular elements at the ribosomal level. Microbiology: The following clindamycin in vitro data are available but their clinical significance is unknown. Clindamycin has been shown to have in vitro activity against canine isolates of the following organisms: Aerobic gram positive cocci, including: Staphylococcus aureus (penicillinase and non-penicillinase producing strains) , Staphylococcus epidermidis, Streptococci (except S. faecalis). Anaerobic gram negative bacilli, including: Bacteroides species, Fusobacterium species. Anaerobic gram positive nonsporeforming bacilli, including: Propionibacterium, Eubacterium, Actinomyces species. Anaerobic and microaerophilic gram positive cocci, including: Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci. Clostridia: Most C. perfringens are susceptible, but other species may be resistant to clindamycin. OVERALL SUSCEPTIBILITY TO CLINDAMYCIN OF ANAEROBES ISOLATED FROM CANINE LESIONS. DATA OBTAINED FROM THREE VETERINARY DIAGNOSTIC LABORATORIES:   Susceptible ≤3.2 µg/mL Resistant ≥4.0 µg/mL All Isolates 122/137 (89%) 15/137 (11%) Clostridium spp. 41/49 (84%) 8/49 (16%) Bacteroides spp. 42/46 (91%) 4/46 (9%) Fusobacterium spp. 16/16 (100%) 0/16 (0%) Peptostreptococcus spp. 15/16 (94%) 1/16 (6%) Actinomyces spp. 5/6 (83%) 1/6 (17%) Proprionibacterium spp. 3/4 (75%) 1/4 (25%) Mycoplasma species: Most mycoplasma species are susceptible to clindamycin. Clindamycin and erythromycin show parallel resistance. Partial cross resistance has been demonstrated between clindamycin, erythromycin and macrolide antibiotics. PHARMACOLOGY Absorption: Clindamycin hydrochloride is rapidly absorbed from the canine gastrointestinal tract. Dogs orally dosed with therapeutic amounts of clindamycin hydrochloride demonstrated antibacterial serum levels of the drug within 15 minutes post-dosing. Canine Serum Levels: Therapeutically effective serum levels of clindamycin hydrochloride can be maintained by oral dosing at the rate of 2.5 mg/lb every 12 hours. Dogs orally dosed with clindamycin hydrochloride at 2.5 mg/lb every 12 hours during a 72 hours dosing regimen continuously maintained ant

Clintabs 25 mg, 400 Tablets (clindamycin) Clintabs 25 mg, 400 Tablets (clindamycin) is an antibiotic for pets that treats soft tissue infections, wound, abscesses, dental infections, and osteomyelitis. CLINTABS TABLETS Pet Medications for Soft Tissue Infections brand of clindamycin hydrochloride tablets INDICATIONS Dogs: Aerobic bacteria: Clintabs (clindamycin hydrochloride) Tablets are indicated for the treatment of soft tissue infections (wounds and abscesses), dental infections and osteomyelitis caused by susceptible strains of Staphylococcus aureus. Anaerobic bacteria: Clintabs (clindamycin hydrochloride) Tablets are indicated for the treatment of soft tissue infections (deep wounds and abscesses), dental infections and osteomyelitis caused by or associated with susceptible strains of Bacteroides fragilis, Bacteroides melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens. (See Microbiology section for additional information.) DESCRIPTION Clintabs (clindamycin hydrochloride) Tablets contain clindamycin hydrochloride which is the hydrated salt of clindamycin. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chlorosubstitution of the 7(R)-hydroxyl group of a naturally produced antibiotic produced by Streptomyces lincolnensis var. lincolnensis . Clintabs Tablets: 25 mg Tablet , each white tablet is marked “C 25” on one side and contains clindamycin hydrochloride equivalent to 25 mg of clindamycin. 75 mg Tablet , each white tablet is marked “C 75” on one side and contains clindamycin hydrochloride equivalent to 75 mg of clindamycin. 150 mg Tablet , each white tablet is marked “C150” on one side and contains clindamycin hydrochloride equivalent to 150 mg of clindamycin. ACTIONS Site and Mode of Action: Clindamycin is an inhibitor of protein synthesis in the bacterial cell. The site of binding appears to be in the 5OS sub-unit of the ribosome. Binding occurs to the soluble RNA fraction of certain ribosomes, thereby inhibiting the binding of amino acids to those ribosomes. Clindamycin differs from cell wall inhibitors in that it causes irreversible modification of the protein-synthesizing subcellular elements at the ribosomal level. Microbiology: The following clindamycin in vitro data are available but their clinical significance is unknown. Clindamycin has been shown to have in vitro activity against canine isolates of the following organisms: Aerobic gram positive cocci, including: Staphylococcus aureus (penicillinase and non-penicillinase producing strains) , Staphylococcus epidermidis, Streptococci (except S. faecalis). Anaerobic gram negative bacilli, including: Bacteroides species, Fusobacterium species. Anaerobic gram positive nonsporeforming bacilli, including: Propionibacterium, Eubacterium, Actinomyces species. Anaerobic and microaerophilic gram positive cocci, including: Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci. Clostridia: Most C. perfringens are susceptible, but other species may be resistant to clindamycin. OVERALL SUSCEPTIBILITY TO CLINDAMYCIN OF ANAEROBES ISOLATED FROM CANINE LESIONS. DATA OBTAINED FROM THREE VETERINARY DIAGNOSTIC LABORATORIES:   Susceptible ≤3.2 µg/mL Resistant ≥4.0 µg/mL All Isolates 122/137 (89%) 15/137 (11%) Clostridium spp. 41/49 (84%) 8/49 (16%) Bacteroides spp. 42/46 (91%) 4/46 (9%) Fusobacterium spp. 16/16 (100%) 0/16 (0%) Peptostreptococcus spp. 15/16 (94%) 1/16 (6%) Actinomyces spp. 5/6 (83%) 1/

Clindamycin Oral Suspension. Use/info: Clindamycin Hydrochloride Drops are indicated for the treatment of soft tissue infections such as wounds, abscesses, dental infections, and osteomyelitis caused by susceptible strains of Staphylococcus aureus.

For the treatment of wounds, abscesses and dental infections. For the treatment of soft tissue.

For the treatment of wounds abscesses and dental infections. For the treatment of soft tissue.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds, abscesses, dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds abscesses dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds, abscesses, dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds abscesses dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds, abscesses, dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds, abscesses, dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds abscesses dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds abscesses dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds abscesses dental infections and soft tissue infections.

Clindamycin Hydrochloride Capsules is used for the treatment of wounds, abscesses, dental infections and soft tissue infections.